Results 51 to 60 of about 1,561,331 (181)

Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression

Drug Design, Development and Therapy, 2016
Dawn Bruijnzeel, Rajiv Tandon Department of Psychiatry, University of Florida College of Medicine, Gainesville, FL, USA Abstract: Antipsychotic agents, utilized for the treatment of a range of psychiatric disorders, differ substantially in terms of ...
Bruijnzeel D, Tandon R
doaj  

Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country

Brazilian Journal of Psychiatry
Objective: The aim of our study was to examine the prevalence of and factors associated with antipsychotic polypharmacy (APP) among patients with serious mental illness in the current South African health care context.
Kerryn S. Armstrong, Henk Temmingh
doaj   +1 more source

Potential to enhance the prescribing of generic drugs in patients with mental health problems in Austria; implications for the future [PDF]

, 2012
Scrutiny over pharmaceutical expenditure is increasing leading to multiple reforms. This includes Austria with measures to lower generic prices and enhance their utilization.
Barbui, Corrado, Piessnegger, J, Gustafsson, Lars L, Gustafsson LL, Lars L Gustafsson, Burkhardt, T., Emanuel eRaschi, Gustafsson, LL, Corrado Barbui, Thomas eBurkhardt, Barbui, C, Schmitzer, M, Godman, Brian, Anna Bucsics, Piessnegger, Jutta, Gustafsson, L. L., Burkhardt, Thomas, Jutta ePiessnegger, Manuela eSchmitzer, Bennie, M, Marion eBennie, Jutta Piessnegger, Godman, B., Raschi, E, Brian eGodman, Anna eBucsics, Godman, B,, Schmitzer M, Bennie, Marion, Godman B, Bucsics, Anna, Corrado eBarbui, Thomas Burkhardt, Piessnegger J, Lars L. Gustafsson, Burkhardt T, Marion Bennie, Brian Godman, Burkhardt, T, Raschi, Emanuel, Bennie, M., Schmitzer, M., Manuela Schmitzer, Raschi, E., Barbui C, Schmitzer, Manuela, Piessnegger, J., Emanuel Raschi, Bucsics, A., Bennie M, Bucsics, A, Bucsics A   +51 more
core   +2 more sources

Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia

Psychology Research and Behavior Management, 2022
Ilaria Riboldi,1 Daniele Cavaleri,1 Chiara A Capogrosso,1 Cristina Crocamo,1 Francesco Bartoli,1 Giuseppe Carrà1,2 1Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; 2Division of Psychiatry, University College London, London,
Riboldi I, Cavaleri D, Capogrosso CA, Crocamo C, Bartoli F, Carrà G   +5 more
doaj  

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia

Neuropsychopharmacology Reports, 2020
Ichihashi et al reported that 43% of patients had antipsychotic polypharmacy. Number of antipsychotics used in patients with schizophrenia in Japan was the greatest among Asian countries.
Norio Yasui‐Furukori, Kazutaka Shimoda
doaj   +1 more source

Discharge and Readmission Rates with Atypical Antipsychotic Agents

, 2002
Objective Newer atypical antipsychotic agents offer many advantages over conventional antipsychotic agents, including a decreased adverse effect burden, improved compliance, and superior efficacy.
Jessica L Goren, Gary M Levin
core   +1 more source

Effect of pharmacological interventions on the fronto-cingulo-parietal cognitive control network in psychiatric disorders: a transdiagnostic systematic review of fMRI studies

Frontiers in Psychiatry, 2016
Executive function deficits such as working memory, decision-making, and attention problems are a common feature of several psychiatric disorders for which no satisfactory treatment exists.
Therese eVan Amelsvoort, Dennis eHernaus
doaj   +1 more source

Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients - Results from an experimental study [PDF]

, 2003
The influence of antipsychotic treatment on the neuropsychological and psychomotor performance of schizophrenic patients is still a subject of investigation.
Soyka, Michael, Kagerer, S., Winter, C., Möller, Hans-Jürgen   +3 more
core   +1 more source

Antipsychotic prescription and polypharmacy among outpatients with schizophrenia in a Nigerian hospital

Nigerian Postgraduate Medical Journal, 2020
Background: International guidelines recommend antipsychotic monotherapy as the ideal treatment option in pharmacotherapy for schizophrenia, though this yields modest outcomes in a third of patients.
Ihechiluru Goodnews Anozie, Bawo O James, Joyce O Omoaregba   +2 more
doaj   +1 more source

Antipsychotics and Risks of Cardiovascular and Cerebrovascular Diseases and Mortality in Dwelling Community Older Adults

Pharmaceuticals
This study aims to investigate the effect of antipsychotic agents on cardiovascular and cerebrovascular diseases (CVD/CEV) and mortality risks in the older population living in a community.
Sylvie Perreault, Laurie-Anne Boivin Proulx, Judith Brouillette, Stéphanie Jarry, Marc Dorais   +4 more
doaj   +1 more source